Nykaa has acquired AMINU, a skincare brand focused on science-backed formulations, for an undisclosed amount. The deal brings the direct-to-consumer label under Nykaa’s ownership, expanding the beauty retailer’s portfolio in the premium skincare segment.
AMINU positions itself as a brand built on the philosophy of “beauty in balance,” combining high-performance ingredients with gentle, restorative care. Its product range targets a broad demographic, addressing diverse skin needs across ages and genders. The company emphasizes formulations that support the skin’s natural repair mechanisms while protecting against environmental stressors, a positioning that has resonated with consumers seeking functional yet accessible skincare.
For Nykaa, the acquisition strengthens its in-house brand ecosystem, which already spans cosmetics, personal care, and wellness. AMINU’s focus on ingredient-led, ageless skincare complements Nykaa’s existing offerings, allowing the company to cater to a growing consumer preference for transparent, efficacy-driven products. The move also deepens Nykaa’s control over product development and supply chain, reducing reliance on third-party brands in a competitive market.
The strategic rationale lies in vertical integration. By owning AMINU, Nykaa can leverage its distribution network, customer insights, and marketing infrastructure to scale the brand across its online platform and physical stores. AMINU, in turn, gains access to Nykaa’s extensive reach, potentially accelerating its growth without the heavy customer acquisition costs typical of standalone D2C brands. The deal also aligns with Nykaa’s broader push into premium skincare, a category with higher margins and repeat purchase behavior.
Post-acquisition, AMINU is expected to operate with greater operational support while retaining its brand identity and product philosophy. Nykaa will likely integrate the brand into its loyalty programs and promotional calendars, driving visibility among its existing customer base. The combined entity aims to capture a larger share of the Indian skincare market, where demand for clinically oriented, balanced formulations continues to rise.